Let’s explore “Antioxidant Protection Assay — lab reference”

…proves kidney outcomes. Keep kidney outcomes separate from antioxidant markers Dr. Purser’s hypothesis moves from redox biology to a proposed clinical benefit. Those steps need different evidence. A change in an antioxidant or cytokine mea…

…er Purser materials emphasize copper handling, genetics and antioxidant pathways. These are distinct explanatory models, not interchangeable diagnoses. Comparing them can help a reader see how the teaching has developed, but the presence of…

… connect A long list of possible benefits can mix symptoms, lab numbers, and disease prevention. Choose a specific outcome and ask what evidence supports it. A benefits list combines unlike kinds of evidence A long list can include symptom…

…and nutritional ideas. That is more informative than simply labeling a testosterone value “low.” The endocrine system includes signaling between organs, so clinicians may investigate whether a problem begins in hormone production or in the …

… health outcomes. How the pieces connect Artery imaging, a lab marker, and a heart attack are different kinds of outcomes. Ask which outcome a claimed therapy was actually shown to change. A plaque image and a clinical event are different…

…pper in the body. Dr. Purser connects NAT2, methylation and antioxidant pathways with this model. A response to a dietary change does not by itself confirm copper toxicity or a genetic cause of fibromyalgia. The model remains separate from …